At critical moments the chances of cancer patients can be improved using
computational pathology

AI-Powered Medicine

At the very core of our technology, we employ a powerful form of machine learning called neural networks (or deep learning). These models are able to identify abnormal tissue patterns like cancer with unprecedented accuracy, and are incredibly useful for pathologists.

Automated Gleason grading in prostate

Clinical Diagnostics

We provide solutions for clinical diagnostics that reduce workflow inefficiencies by streamlining the process of pathological examination, improving its overall quality, and reducing its cost.

Our current product portfolio focuses on breast and prostate cancer diagnostics, and we are expanding it to applications involving colorectal, lung and kidney diseases.

Automated tissue morphology detection in colon

Life Sciences

We support CROs and biopharma with AI-powered solutions to identify novel pathology-based biomarkers that can accelerate drug development.

We offer a flexible and interoperable AI platform to create biomarker solutions, ready to accommodate any size of workload at global scale.

Automated lymphocyte detection in immunohistochemistry

Scientific Work

An overview of our most significant work in collaboration with the Computational Pathology Group. For a complete overview of the research work, please visit the group page.